Telesis Bio Inc.
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
Previously recorded as Codex Dna, Inc. (to 2023)
9
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 13, 2027The maintenance fee for GENETICALLY ENGINEERED VIBRIO sp. AND USES THEREOF (US 10,377,997) comes due Feb 13, 2027. Unpaid by Aug 13, 2027, it lapses early.
- 1 fee due Mar 5, 2027The maintenance fee for Methods of Cloning Nucleic Acids or Producing Proteins in a Low Endotoxin Organism (US 11,746,321) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Materials and Methods for the Synthesis of Error-Minimized Nucleic Acid Molecules (US 11,884,916) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,704,690 | Synthesis of Error-Minimized Nucleic Acid Molecules In force · High confidence | In force | High confidence | |
| US 10,041,060 | Method of Nucleic Acid Cassette Assembly In force · Medium confidence | In force | Medium confidence | |
| US 9,534,251 | In Vitro Recombination Method In force · High confidence | In force | High confidence | |
| US 8,497,069 | Amplification and Cloning of Single DNA Molecules Using Rolling Circle Amplification In force · High confidence | In force | High confidence | |
| US 8,173,368 | Programmable Oligonucleotide Synthesis In force · High confidence | In force | High confidence | |
| US 8,367,335 | Programmable Oligonucleotide Synthesis In force · High confidence | In force | High confidence | |
| US 10,876,110 | Synthesis of Sequence-Verified Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,644,225 | Programmable Oligonucleotide Synthesis In force · High confidence | In force | High confidence | |
| US 9,593,329 | Assembly of Large Nucleic Acids In force · Medium confidence | In force | Medium confidence | |
| US 10,266,865 | Methods for in Vitro Joining and Combinatorial Assembly of Nucleic Acid Molecules In force · High confidence | In force | High confidence |
Also on record, not counted in the 31: 6 patents in force now held by others · 3 lapsed for an unpaid fee · 9 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending